EU intends to ban deoxyarbutin for cosmetics
India has imposed anti-dumping duty on a Chinese chemical used in pharma industry and aluminium foil to protect domestic industry from cheap imports.
While an anti-dumping duty of up to $1.63 per kg was imposed on Aluminium foil, up to $8.71 per kg duty was slapped on imports of amoxicillin, used in pharmaceuticals. The duty on both the products would be effective for a period of five years, the finance ministry has said in separate notifications.
The commerce ministry’s investigation arm — Directorate General of Anti-Dumping and Allied Duties (DGAD) — in the separate probe had concluded that these products were dumped into India and that has caused material injury to the domestic industry.
Hindalco Industries, Raviraj Foils and Jindal India had filed the application for an anti-dumping probe into imports of aluminium foil, used for packing of medicines, processed foods and cigarette. Similarly, Aurobindo Pharma had filed the application for an anti-dumping probe on Amoxycillin from China.
Countries initiate anti-dumping probe to determine if the domestic industry has been hurt by flooding of below-cost import. As a counter-measure, they come up with duties under the multilateral WTO regime.
Anti-dumping steps are taken to ensure fair trade and provide a level-playing field to the domestic industry. They are not a measure to restrict import or cause an unjustified increase in cost of products.
Looking for chemical products? Let suppliers reach out to you!
2026-07-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The EU issued a formal ban on lambda-cyfluthrin
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
Safic-Alcan Acquires Anders, Expanding Latin American Presence
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Procter & Gamble Exits Pakistan Amid Economic Pressures, Ending Three Decades of Operations
-
DKSH Expands Partnership with Assessa to Distribute Botanical Ingredients Across China
-
Natura &Co Returns to Profitability in Q2 with Strong Latin America Performance
-
SkinCeuticals Unveils AGE Interrupter Ultra Serum to Target Skin Laxity
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
KKR Acquires Korea’s Samhwa in $528 Million Deal
Recommend Reading
-
O Boticário Enters the US Market with Mushroom Fragrance Innovation
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Toray to Transfer Stake in Soda Aromatic to Samyang
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
L'Oréal's Performance in the First Half of 2025 Was Solid: Growth Across All Business Lines and Continued Improvement in Profit Margins
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
“Shutdown Equals Price Hike”: TDI Market Enters a New Era of “Scarcity Games”
-
Costs Rise, Hydrogen Peroxide Market Prices See an Increase
-
Supply-Demand Contradiction Continues, Acrylonitrile Market Prices in China Decline Further